DEUTSCHE BANK AG\

Holdings History for Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

Symbol: CGEM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$6,071,683	586,636	+14,898	+2.6%	$10.35	Q4 2025
30 Sep 2025	0%	+0%	$3,390,406	571,738	+4,957	+0.87%	$5.93	Q3 2025
30 Jun 2025	0%	-0%	$4,267,861	566,781	-8,750	-1.5%	$7.53	Q2 2025
31 Mar 2025	0%	-0%	$4,356,770	575,531	-4,605		$7.57	Q1 2025
31 Dec 2024	0%	+0%	$7,066,057	580,136	+19,263		$12.18	Q4 2024
30 Sep 2024	0%	+0%	$9,389,014	560,873	+5,806		$16.74	Q3 2024
30 Jun 2024	0%	+0%	$9,680,368	555,067	+5,791		$17.44	Q2 2024
31 Mar 2024	0%	+0%	$9,359,663	549,276	+3,692		$17.04	Q1 2024
31 Dec 2023	0%	+0%	$5,559,501	545,584	+540,967	+11717%	$10.19	Q4 2023
30 Sep 2023	0%	-0%	$41,784	4,617	-3,676	-44%	$9.05	Q3 2023
30 Jun 2023	0%	-0%	$89,233	8,293	-7,670	-48%	$10.76	Q2 2023
31 Mar 2023	0%	+0%	$163,302	15,963	+3,654	+30%	$10.23	Q1 2023
31 Dec 2022	0%	+0%	$129,860	12,309	+204	+1.7%	$10.55	Q4 2022
30 Sep 2022	0%	-0%	$155,000	12,105	-1,993	-14%	$12.80	Q3 2022
30 Jun 2022	0%	-0%	$181,000	14,098	-264	-1.8%	$12.84	Q2 2022
31 Mar 2022	0%	-0%	$150,000	14,362	-1,662	-10%	$10.44	Q1 2022
31 Dec 2021	0%	+0%	$247,000	16,024	+822	+5.4%	$15.41	Q4 2021
30 Sep 2021	0%	+0%	$343,000	15,202	+6,882	+83%	$22.56	Q3 2021
30 Jun 2021	0%	-0%	$214,000	8,320	-262	-3.1%	$25.72	Q2 2021
31 Mar 2021	0%	+0%	$358,000	8,582	+8,582	NEW	$41.72	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.